Featured Article

Dyslipidemia and Atherosclerosis Clinical Practice Guidelines

Dyslipidemia and Atherosclerosis Clinical Practice Guidelines

New guidelines for dyslipidemia management and atherosclerosis prevention include a wider range of disease stages and more aggressive intervention.

Latest Features

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.

Statins Limit Vaccine Efficacy of Influenza Strain

Statins Limit Vaccine Efficacy of Influenza Strain

Statin use modified vaccine effectiveness and influenza risk for A(H3N2) infection but not for A(H1N1).

Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C

Higher Vitamin D Levels May Related to Higher Total Cholesterol, HDL-C

Vitamin D may influence cardiovascular disease risk via its effect on lipid levels.

Considering Cardiovascular Risks of Antidiabetic Drugs

Considering Cardiovascular Risks of Antidiabetic Drugs

A review of current antidiabetic drug treatments available and their individual cardiovascular risk profiles.

PCSK9 Inhibitors: Breakthrough in LDL-C Reduction, But Comes at a Cost

PCSK9 Inhibitors: Breakthrough in LDL-C Reduction, But Comes at a Cost

PCSK9 inhibitors may offer hope to patients with familial hypercholesterolemia who cannot tolerate or achieve goal LDL-C levels with statins.

LATEST NEWS

Total Cholesterol, Low-Density Lipoprotein Cholesterol Levels Affect Parkinson's Risk

Total Cholesterol, Low-Density Lipoprotein Cholesterol Levels Affect Parkinson's Risk

A decreased risk in Parkinson's disease has been associated with total serum cholesterol and low-density lipoprotein cholesterol in men not on statin therapy.

Statins May Increase Risk for Mortality in Type 2 Diabetes

Statins May Increase Risk for Mortality in Type 2 Diabetes

In a study,patients with type 2 diabetes presented better glycemic control and had higher risk for mortality when not taking statins.

Cholesterol Significantly Reduced by Blocking Angiopoietin-like 3 Gene

Cholesterol Significantly Reduced by Blocking Angiopoietin-like 3 Gene

Two research groups successfully reduced cholesterol in humans to block the angiopoietin-like 3 gene.

Refill Synchronization Beneficial for Medication Adherence

Refill Synchronization Beneficial for Medication Adherence

Appointment-based models improve medication-taking behavior.

Sitagliptin Improves Triglycerides and Glucose Tolerance

Sitagliptin Improves Triglycerides and Glucose Tolerance

Sitagliptin improved several lipid parameters for men who were overweight and had prediabetes.

Dapagliflozin May Benefit Progression of Atherosclerosis

Dapagliflozin May Benefit Progression of Atherosclerosis

Dapagliflozin improved endothelial function in patients with type 2 diabetes.

Long-Term Outcomes of Evacetrapib on Cardiovascular Outcomes

Long-Term Outcomes of Evacetrapib on Cardiovascular Outcomes

Evacetrapib does not affect the primary efficacy end point of first occurrence of any component of a composite of death from cardiovascular causes in patients with high-risk vascular disease.

Targeted Approach Needed for Cholesterol Screenings

Targeted Approach Needed for Cholesterol Screenings

Study shows prevalence of atherosclerotic cardiovascular disease risk among adults under 50 without diabetes is low.

Are Patients Aware the Importance of Cholesterol Management?

Are Patients Aware the Importance of Cholesterol Management?

An American Heart Association survey found that patients felt least informed about the differences in cholesterol types and goals for cholesterol management.

Cognition Not Adversely Affected by Evolocumab With Statin Therapy

Cognition Not Adversely Affected by Evolocumab With Statin Therapy

No differences were seen in measures of executive function between the evolocumab and placebo groups.

Sign Up for Free e-Newsletters